📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
94 announcements match the current filters (relevance ≥ 5).
DCM Shriram Recommends Rs 4 Final Dividend and Announces Rs 101 Cr Chemicals Expansion
DCM Shriram has reported its audited FY26 results and recommended a final dividend of Rs 4 per share, bringing the total annual payout to Rs 11.20 per share. The company is aggressively expanding its Advanced Materials segment through a Rs 101 crore investment in its subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL). This investment aims to increase Formulated Resins capacity by 36,000 TPA, reaching a total of 50,000 TPA. Additionally, the board has approved the cancellation of 3.9 million forfeited equity shares, subject to shareholder approval.
Key Highlights
Recommended final dividend of 200% (Rs 4 per share), totaling 560% (Rs 11.20 per share) for FY26.
Approved Rs 101 crore capital expenditure for subsidiary HSCL to add 36,000 TPA of Formulated Resins capacity.
Total Formulated Resins capacity to reach 50,000 TPA following the expansion project.
Board approved financial assistance of up to Rs 100 crore to HSCL through a mix of equity and debt.
Proposed cancellation of 39,00,000 forfeited equity shares of face value Rs 2 each.
👀 What to Watch
Investors should note the company's focus on the high-growth Advanced Materials segment and its commitment to shareholder returns through a healthy dividend yield. The expansion project signals long-term growth potential in the chemicals business.
DCM Shriram FY26 PAT Jumps 42% to ₹856 Cr; Board Recommends 200% Final Dividend
DCM Shriram reported a resilient FY26 with consolidated revenue growing 12% to ₹14,264 crore and PAT surging 42% to ₹856 crore. The bottom line was significantly bolstered by a one-time deferred tax credit of ₹239 crore, though operational PBDIT also grew a healthy 15% to ₹1,694 crore. Growth was primarily driven by the Chemicals segment, Shriram Farm Solutions, and a milestone performance by Fenesta Building Systems. The company continues its strategic shift toward advanced materials with the commissioning of its ECH plant and new acquisitions in the resins space.
Key Highlights
Consolidated FY26 PAT reached ₹856 crore (+42% YoY), including a one-time deferred tax credit of ₹239 crore.
Fenesta Building Systems crossed the ₹1,100 crore revenue milestone, growing 28% with an order book of ₹1,498 crore.
Chemicals business saw 12% growth in caustic soda volumes and commissioned a 52,000 TPA Epichlorohydrin (ECH) plant in April 2026.
Shriram Farm Solutions revenue increased 18% to ₹1,689 crore, led by record sales in the Research Wheat segment.
Board recommended a final dividend of 200%, bringing the total dividend for the year to 560%.
👀 What to Watch
Investors should focus on the strong operational growth in the Chemicals and Fenesta segments, which are offsetting pressures in the Sugar business. The stock remains attractive for long-term holders given the aggressive expansion into high-margin advanced materials and consistent dividend payouts.
DCM Shriram FY26 PAT Jumps 42% to ₹856 Cr; Total Dividend Declared at 560%
DCM Shriram reported a solid FY26 with revenue growing 12% to ₹13,538 crore and PAT rising 42% to ₹856 crore, supported by a ₹239 crore deferred tax credit. The Chemicals segment was a standout performer with 38% revenue growth following capacity expansions, while Fenesta Building Systems grew 28%. The company is pivoting towards advanced materials with the commissioning of its Epichlorohydrin plant in April 2026. A final dividend of 200% has been recommended, totaling 560% for the full year.
Key Highlights
FY26 Consolidated Revenue reached ₹13,538 crore (up 12% YoY) and PBDIT stood at ₹1,694 crore (up 15% YoY).
Chemicals revenue surged 38% to ₹3,832 crore in FY26, driven by a 12% volume growth in Caustic Soda.
Fenesta Building Systems achieved 28% revenue growth with a strong year-end order book of ₹1,498 crore.
Commissioned 52,000 TPA Epichlorohydrin plant in April 2026 to strengthen the advanced materials value chain.
Total dividend for FY26 stands at 560% (₹11.20 per share) following a final dividend recommendation of 200%.
👀 What to Watch
The company's diversification into high-margin advanced materials and strong growth in the Fenesta segment offset cyclicality in the sugar business. Long-term investors should monitor the utilization levels of newly commissioned chemical capacities.
DCM Shriram Recommends Rs 4 Final Dividend, Cancels 39L Forfeited Shares & Plans Rs 101 Cr Capex
DCM Shriram has recommended a final dividend of Rs 4 per share, bringing the total dividend for FY26 to Rs 11.20 per share (560%). The board also approved the cancellation of 39,00,000 forfeited equity shares, subject to shareholder approval. Furthermore, the company's subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), will undertake a Rs 101 crore capital expenditure to expand its Formulated Resins capacity by 36,000 TPA. DCM Shriram will provide financial assistance of up to Rs 100 crore to HSCL through a mix of equity and debt to support this growth.
Key Highlights
Recommended final dividend of 200% (Rs 4 per share), totaling Rs 11.20 for the full financial year.
Proposed cancellation of 39,00,000 forfeited equity shares of face value Rs 2 each.
Subsidiary HSCL to invest Rs 101 crores to increase Formulated Resins capacity from 14K TPA to 50K TPA.
DCM Shriram to provide financial assistance of up to Rs 100 crores to HSCL for the expansion.
The 37th Annual General Meeting (AGM) is scheduled for August 18, 2026.
👀 What to Watch
Investors should note the healthy total dividend yield and the company's strategic focus on expanding its Advanced Materials portfolio. The expansion in chemicals capacity signals long-term growth potential in higher-margin segments.
DCM Shriram Recommends Rs 4 Final Dividend; Plans Rs 101 Cr Expansion in Chemicals
DCM Shriram has announced a final dividend of Rs 4 per share, bringing the total dividend for FY26 to Rs 11.20 (560% of face value). The company is expanding its specialty chemicals footprint through its subsidiary HSCL with a Rs 101 crore investment to add 36,000 TPA of Formulated Resins capacity. Additionally, the board has approved the cancellation of 3.9 million forfeited equity shares, subject to shareholder approval. To support the expansion, the company will provide financial assistance of up to Rs 100 crore to its subsidiary.
Key Highlights
Recommended final dividend of Rs 4 per share, totaling Rs 11.20 for the full financial year 2025-26
Approved Rs 101 crore capital expenditure for subsidiary HSCL to increase Formulated Resins capacity by 36K TPA
Total Formulated Resins capacity to reach 50K TPA upon completion of the expansion project
Cancellation of 39,00,000 forfeited equity shares of Rs 2 each approved by the board
Financial assistance of up to Rs 100 crore approved for HSCL through a mix of equity and debt
👀 What to Watch
Investors should find the high dividend payout and the strategic expansion into high-margin specialty chemicals encouraging. The stock remains a watch for long-term growth in the advanced materials segment.
DCM Shriram FY26 Results: Total Dividend of Rs 11.20/Share and Rs 101 Cr Capex for Subsidiary
DCM Shriram has announced its FY26 audited results along with a final dividend recommendation of Rs 4 per share, bringing the total annual payout to Rs 11.20 per share (560%). The company is aggressively expanding its chemicals portfolio with a Rs 101 crore capex plan for its subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), to increase Formulated Resins capacity by 36,000 TPA. To support this, DCM Shriram will provide financial assistance of up to Rs 100 crore to HSCL. Additionally, the board has proposed the cancellation of 3.9 million forfeited equity shares, pending shareholder approval.
Key Highlights
Recommended final dividend of Rs 4 per share (200%), making the total FY26 dividend Rs 11.20 per share.
Approved Rs 101 crore capex for subsidiary HSCL to expand Formulated Resins capacity from 14K TPA to 50K TPA.
Committed up to Rs 100 crore in financial assistance to HSCL through a mix of equity and debt.
Proposed cancellation of 39,00,000 forfeited equity shares of face value Rs 2 each.
The 37th Annual General Meeting is scheduled for August 18, 2026, to seek shareholder approvals.
👀 What to Watch
Investors should find the high dividend payout and the strategic expansion into advanced chemical materials encouraging for long-term value. Monitor the execution of the capacity expansion at HSCL as it scales the chemicals business.
DCM Shriram Recommends Rs 4 Final Dividend and Announces Rs 101 Cr Capex for Chemicals Expansion
DCM Shriram has recommended a final dividend of Rs 4 per share, bringing the total dividend for FY26 to Rs 11.20 per share. The company approved a capital expenditure of Rs 101 crore for its wholly-owned subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), to expand its Formulated Resins capacity by 36,000 TPA. To support this, the board approved financial assistance of up to Rs 100 crore to HSCL through equity and debt. Additionally, the board proposed the cancellation of 3.9 million forfeited equity shares, pending shareholder approval.
Key Highlights
Recommended final dividend of 200% (Rs 4 per share), totaling 560% (Rs 11.20 per share) for FY26.
Approved Rs 101 crore capex for HSCL to increase Formulated Resins capacity from 14K TPA to 50K TPA.
Authorized financial assistance of up to Rs 100 crore to subsidiary HSCL via equity and debt mix.
Proposed cancellation of 39,00,000 forfeited equity shares of Rs 2 each.
Audited financial results for FY26 approved with an unmodified audit opinion from Deloitte.
👀 What to Watch
Investors should view the consistent dividend payout and the strategic expansion into advanced chemical materials as positive indicators of long-term growth. Monitor the progress of the HSCL capacity expansion as it scales the company's specialty chemicals portfolio.
DCM Shriram Recommends Rs 4 Final Dividend; Plans Rs 101 Cr Expansion for HSCL
DCM Shriram has announced its FY26 results along with a final dividend of Rs 4 per share, bringing the total annual dividend to Rs 11.20 (560%). The company is aggressively expanding its Advanced Materials portfolio with a Rs 101 crore investment in subsidiary HSCL to increase Formulated Resins capacity by 36,000 TPA. Additionally, the board has approved the cancellation of 39 lakh forfeited equity shares and provided financial assistance of Rs 100 crore to HSCL. The statutory auditors have issued an unmodified opinion on the annual financial results.
Key Highlights
Recommended final dividend of Rs 4 per share (200%), totaling Rs 11.20 (560%) for the full financial year 2025-26.
Approved Rs 101 crore capex for subsidiary Hindusthan Specialty Chemicals (HSCL) to reach 50,000 TPA capacity.
Board to provide financial assistance up to Rs 100 crore to HSCL through a mix of equity and debt.
Proposal to cancel 39,00,000 forfeited equity shares of face value Rs 2 each, subject to shareholder approval.
Audited financial results for the year ended March 31, 2026, released with an unmodified audit opinion.
👀 What to Watch
Investors should find the 560% total dividend for the year attractive and monitor the growth in the Advanced Materials segment following the HSCL expansion. The stock remains a watch for long-term growth in the chemicals and specialty resins space.
DCM Shriram Recommends Rs 4 Final Dividend; Total FY26 Payout Reaches Rs 11.20 Per Share
DCM Shriram has recommended a final dividend of Rs 4 per share, bringing the total dividend for FY25-26 to Rs 11.20 per share, representing a 560% payout on face value. Alongside the dividend, the company announced a Rs 101 crore capital expenditure for its subsidiary, Hindusthan Specialty Chemicals Ltd, to expand resin capacity by 36,000 TPA. The board also approved the cancellation of 39 lakh forfeited equity shares and provided financial assistance of up to Rs 100 crore to its subsidiary for growth initiatives. These announcements were made following the approval of the audited financial results for the year ended March 31, 2026.
Key Highlights
Recommended final dividend of Rs 4 per share (200%), totaling Rs 11.20 for the full financial year.
Approved Rs 101 crore capex for subsidiary HSCL to increase Formulated Resins capacity from 14K to 50K TPA.
Authorized financial assistance of up to Rs 100 crore to HSCL through a mix of equity and debt.
Board approved the cancellation of 3,900,000 forfeited equity shares of face value Rs 2 each.
The 37th Annual General Meeting (AGM) is scheduled for August 18, 2026, to finalize these proposals.
👀 What to Watch
Investors should benefit from the healthy dividend yield and monitor the progress of the chemicals segment expansion which signals long-term growth. The stock remains attractive for those seeking a combination of regular income and industrial capacity expansion.
DCM Shriram Sells Surplus Land in Telangana for Rs 70.65 Crore
DCM Shriram Limited has successfully completed the sale of surplus land admeasuring approximately 5.96 acres (5 Acres 38.56 Guntas) in Ranga Reddy District, Telangana. The transaction was finalized on May 4, 2026, for a total cash consideration of Rs 70.65 crores. The buyer, Skade Realty LLP, is an independent third party, ensuring the deal is not a related party transaction. This move is part of the company's strategy to monetize non-core assets and improve liquidity.
Key Highlights
Sold 5 Acres 38.56 Guntas of surplus land in Mokila Village, Telangana
Received total cash consideration of Rs 70.65 crores
Transaction completed on May 4, 2026, with Skade Realty LLP
Sale is not a related party transaction and involves no promoter interest
Asset disposal helps in unlocking value from non-core holdings
👀 What to Watch
Investors should view this as a positive step towards efficient capital allocation and asset monetization. The cash inflow of Rs 70.65 crore will likely strengthen the balance sheet or fund ongoing capital expenditure.
DCM Shriram Commences 15 MW Average Renewable Power Injection at Kota Complex
DCM Shriram has announced the commencement of renewable power injection for its Wind Solar Hybrid project at the Kota Complex. Currently, the injection has started for a partial capacity with an average of ~15 MW. This is part of a larger ~68 MW (~34 MW average) project designed to replace the existing 40 MW coal-based power facility. The project is being implemented through a Special Purpose Vehicle, JSW Renew Energy Thirty Two Limited, marking a significant shift toward sustainable energy operations.
Key Highlights
Commenced renewable power injection with an average capacity of ~15 MW at Kota Complex.
Project is part of a total ~68 MW (~34 MW average) Wind Solar Hybrid Renewable Power setup.
Aims to replace the existing 40 MW coal-based power plant, improving the company's ESG profile.
Project executed through SPV JSW Renew Energy Thirty Two Limited.
Transition is expected to reduce carbon footprint and potentially lower long-term energy costs.
👀 What to Watch
Investors should monitor the progress of the remaining capacity commissioning as it will further reduce reliance on coal. This move strengthens the company's sustainability credentials and could lead to operational cost savings in the long run.
DCM Shriram and Teknor Apex Forge JV "PolyTek" for Advanced Polymer Compounds
DCM Shriram's subsidiary, Shriram Polytech Ltd., has entered into a joint venture with Teknor Apex B.V. to form a new entity named "PolyTek." This partnership combines Shriram's domestic manufacturing strength in vinyl compounds with Teknor Apex's global formulation expertise in material science. The JV aims to deliver high-performance specialty polymer solutions for diverse industrial sectors in India and international markets. This strategic move is designed to capture growth in India's expanding manufacturing ecosystem and enhance supply chain resilience.
Key Highlights
Formation of a new Joint Venture brand 'PolyTek' between Shriram Polytech and Teknor Apex B.V.
Combines Shriram's local manufacturing footprint with Teknor Apex's 100 years of global material science expertise.
Targeting high-growth sectors including automotive, medical, consumer products, and wire & cable.
Strategic focus on delivering technically advanced specialty polymer solutions and high-performance vinyl compounds.
Aims to leverage India's position as a global manufacturing hub to serve both domestic and global customers.
👀 What to Watch
This JV is a positive strategic development that shifts DCM Shriram toward higher-margin specialty polymer products. Investors should monitor the JV's impact on the company's chemical segment margins and revenue growth in the coming fiscal years.
DCM Shriram to Sell 50% Stake in Shriram Polytech to Teknor Apex for $5.6 Million
DCM Shriram has approved the sale of a 50% equity stake in its wholly-owned subsidiary, Shriram Polytech Limited (SPL), to Teknor Apex B.V. for a cash consideration of USD 5.6 million. Following the transaction, SPL will transition from a subsidiary to a Joint Venture, aiming to combine domestic manufacturing with global formulation expertise in specialty polymers. As of March 31, 2025, SPL contributed 1.58% (₹201.63 Crores) to the company's total turnover and 1.13% (₹78.36 Crores) to its net worth. The deal is expected to close by April 23, 2026, and focuses on high-performance sustainable polymer solutions.
Key Highlights
Divestment of 50% stake in Shriram Polytech Limited for a cash consideration of USD 5.6 million
SPL contributed ₹201.63 Crores to turnover and ₹78.36 Crores to net worth in FY25
Transition of SPL from a wholly-owned subsidiary to a 50:50 Joint Venture with Teknor Apex
Strategic focus on high-performance and technically advanced sustainable specialty polymer solutions
Transaction expected to be completed by April 23, 2026
👀 What to Watch
Investors should view this as a positive strategic move to scale the specialty polymer business through global technical collaboration. Monitor the JV's performance and its contribution to segment margins in the coming quarters.
DCM Shriram to Sell 50% Stake in Shriram Polytech to Teknor Apex for USD 5.6 Million
DCM Shriram has approved the sale of a 50% equity stake in its wholly-owned subsidiary, Shriram Polytech Limited (SPL), to Netherlands-based Teknor Apex B.V. for USD 5.6 million. Following the transaction, SPL will transition from a subsidiary to a Joint Venture, aiming to leverage Teknor Apex's global formulation expertise in specialty polymers. SPL contributed approximately 1.58% (₹201.63 crore) to DCM Shriram's total turnover and 1.13% (₹78.36 crore) to its net worth in FY25. This strategic partnership is intended to accelerate growth in high-performance and sustainable polymer solutions.
Key Highlights
Sale of 50% equity stake in Shriram Polytech Limited for a cash consideration of USD 5.6 million.
Shriram Polytech will be reclassified as a Joint Venture instead of a wholly-owned subsidiary.
SPL reported a turnover of ₹201.63 crore and a net worth of ₹78.36 crore as of March 31, 2025.
The transaction is expected to be completed by April 23, 2026.
Partnership aims to combine domestic manufacturing with global technical capabilities in vinyl and specialty compounds.
👀 What to Watch
Investors should monitor the scaling of the new Joint Venture as it provides DCM Shriram access to global technology and high-growth specialty polymer markets. The cash inflow and strategic de-risking of the unit are positive indicators for long-term value creation in the chemicals segment.
CARE Ratings Assigns 'A-' Rating to DCM Shriram International's Rs 267 Cr Facilities
DCM Shriram International Limited (DCMSIL) has received its initial credit ratings from CARE Ratings Limited for its bank facilities and fixed deposits. The agency assigned a 'Care A-; Stable' rating for long-term bank facilities of Rs. 125.44 crore and fixed deposits of Rs. 15.00 crore. Additionally, short-term bank facilities worth Rs. 127.22 crore were assigned a 'Care A2+' rating. These ratings establish a credit profile for the company, which is essential for its future borrowing costs and financial credibility.
Key Highlights
Long-term bank facilities of Rs. 125.44 crore assigned 'Care A-; Stable' rating
Short-term bank facilities of Rs. 127.22 crore assigned 'Care A2+' rating
Fixed Deposit program of Rs. 15.00 crore assigned 'Care A-; Stable' rating
Total rated instruments and facilities aggregate to approximately Rs. 267.66 crore
👀 What to Watch
Investors should consider this a positive development as it validates the company's creditworthiness and may help in securing lower interest rates for future debt. Monitor the company's ability to maintain these investment-grade ratings in upcoming quarterly reviews.
DCM Shriram Industries Credit Rating Downgraded to CARE A-; Outlook Stable
CARE Edge Ratings has downgraded DCM Shriram Industries' long-term bank facilities and fixed deposits from CARE A+ to CARE A-. The short-term rating was also revised downward from CARE A1+ to CARE A2+. These changes follow the company's performance review for FY25 and the implementation of a Composite Scheme of Arrangement approved by the NCLT. Although the 'Negative Rating Watch' has been removed, the multi-notch downgrade indicates a shift in the company's credit profile.
Key Highlights
Long-term bank facilities downgraded from CARE A+ to CARE A- with a Stable outlook.
Short-term bank facilities lowered from CARE A1+ to CARE A2+.
Fixed deposit rating downgraded to CARE A- from CARE A+.
Ratings removed from 'Rating Watch with Negative implications' post-NCLT scheme approval.
Review based on financial performance for FY 2024-25 and 9M ended Dec 31, 2025.
👀 What to Watch
The downgrade reflects increased credit risk; investors should evaluate the impact of the corporate restructuring on the company's balance sheet. Monitor upcoming quarterly results to see if operational performance can offset the potential for higher borrowing costs.
DCM Shriram Fully Commissions 52,000 TPA Epichlorohydrin Plant in Gujarat
DCM Shriram Limited has successfully commissioned the remaining 17,000 TPA capacity of its Epichlorohydrin (ECH) plant at its Jhagadia complex in Gujarat. This follows the initial commissioning of 35,000 TPA in October 2025, bringing the total operational capacity to 52,000 TPA. The full commissioning of this facility marks a significant milestone in the company's chemical segment expansion. This move is expected to drive volume growth and enhance the company's presence in the specialty chemicals market.
Key Highlights
Commissioned final 17,000 TPA capacity on April 1, 2026
Total Epichlorohydrin (ECH) plant capacity reached 52,000 TPA
Plant is located at the chemical complex in Jhagadia, Bharuch District, Gujarat
Completion follows the first phase of 35,000 TPA commissioned in October 2025
👀 What to Watch
Investors should view this as a positive development for long-term growth and monitor the plant's contribution to the chemical segment's revenue and margins in the coming quarters.
DCM Ltd Shareholders Approve Material Related Party Transaction with 97.67% Majority
DCM Limited has received shareholder approval for a material related party transaction (RPT) with Purearth Infrastructure Limited via a postal ballot. The ordinary resolution was passed with an overwhelming 97.67% of valid votes cast in favour by public shareholders. In compliance with SEBI regulations, promoter group votes totaling 18,72,627 were excluded from the final count as they were interested parties. This approval allows the company to proceed with its planned business arrangements with Purearth.
Key Highlights
Ordinary resolution for RPT with Purearth Infrastructure Limited passed with 97.67% majority of valid votes.
A total of 1,120,603 votes were cast in favour, compared to 26,734 votes against the proposal.
Promoter group votes amounting to 1,872,627 shares were invalidated for this specific resolution due to their interested status.
The voting process was conducted via remote e-voting from February 25 to March 26, 2026, involving 24,681 eligible shareholders.
👀 What to Watch
Investors should monitor the specific financial terms and execution of the transactions with Purearth Infrastructure to ensure they contribute to long-term value. The high level of public shareholder support suggests confidence in the management's corporate governance regarding this transaction.
DCM Limited Faces Arbitration from GCD Prime Over 67.275-Acre Project Termination
DCM Limited has received a notice for invocation of arbitration from its developer partner, GCD Prime, regarding a 67.275-acre land parcel in Hisar, Haryana. This follows DCM's decision in November 2025 to terminate the Joint Development Agreement (JDA) and forfeit payments due to the developer's failure to resolve a license suspension by the Haryana Government. The project was intended for an affordable residential colony under the Deen Dayal Jan Awas Yojna. While the financial impact is currently undeterminable, the legal battle creates uncertainty regarding the monetization of this significant land asset.
Key Highlights
Arbitration invoked by GCD Prime under Section 21 of the Arbitration and Conciliation Act, 1996.
Dispute involves a Joint Development Agreement dated August 11, 2022, for a 67.275-acre project.
DCM had previously terminated the agreement on November 1, 2025, citing inordinate delays and breaches.
The developer failed to revoke a license suspension issued by the Haryana Government for the Hisar site.
Quantum of claims and financial implications are not yet determinable by the company.
👀 What to Watch
Investors should closely monitor the arbitration progress as it directly impacts the development and valuation of a major real estate asset in Hisar. Any adverse ruling could delay project timelines or impact the company's ability to retain forfeited amounts.
DCM Shriram Industries: Promoter Urvashi Tilakdhar to Acquire 2.93% Stake
Urvashi Tilakdhar, a member of the promoter group, has filed a disclosure to acquire 25,45,373 shares of DCM Shriram Industries, representing a 2.93% stake. This transaction is an inter-se transfer among promoters, which is typically exempt from open offer requirements under SEBI SAST Regulations. Post-acquisition, the total promoter and PAC (Persons Acting in Concert) holding will increase from 47.18% to 50.11%. This move effectively consolidates majority control within the promoter group.
Key Highlights
Proposed acquisition of 25,45,373 equity shares representing 2.93% of the total share capital.
Promoter and PAC holding to increase from 4,10,44,742 shares (47.18%) to 4,35,90,115 shares (50.11%).
Disclosure filed under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The transaction represents an internal restructuring/realignment of shares within the promoter group.
👀 What to Watch
This is a routine internal promoter group transaction and does not change the company's fundamental outlook; investors should maintain their current positions.
